Progress in the Treatment of Myelodysplastic Syndromes (MDS)
Event Date
Monday, September 14, 2026
1:30 PM - 2:30 PM ET
Presented in Collaboration with:
- The MDS Foundation
- AAMDSIF - The Aplastic Anemia and MDS International Foundation
- Advanced Practitioner Society for Hematology and Oncology (APSHO)
- American Cancer Society
- American Psychosocial Oncology Society
- American Society of Clinical Oncology
- Association for Molecular Pathology
- Association of Clinicians for the Underserved
- Association of Oncology Social Work
- Black Womens Health Imperative
- BMT InfoNet
- Blood Cancer United (formerly Leukemia and Lymphoma Society)
- Bone Marrow and Cancer Foundation
- Cancer Justice
- Cancer Nation
- Cancer Support Community
- Caregiver Action Network
- DKMS We Delete Blood Cancer
- Intercultural Cancer Council
- Joe's House
- Latinas Contra Cancer
- MDS Alliance
- Multinational Association of Supportive Care in Cancer
- National Association of Social Workers
- National Bone Marrow Transplant Link
- National Comprehensive Cancer Network (NCCN) NCCN Guidelines for Patients
- National LGBT Cancer Network
- National Organization for Rare Disorders (NORD)
- NeedyMeds
- NMDPsm
- Prevent Cancer Foundation
- Redes en Acción The National Latino Cancer Research Network
- Scott Hamilton CARES Foundation
- The LGBT Cancer Project
- Triage Cancer
- Vital Options International
This activity is supported by Bristol Myers Squibb. CancerCare’s application for continuing education credits for this program is supported by the Diana Napoli Fund.
Topics Covered
- Discussion of Myelodysplastic Syndromes (MDS)
- Diagnosis, Staging & Current Standard of Care
- The Role of Hematopathology Examination of a Sample of Your Bone Marrow in Making a Definitive Diagnosis of MDS
- New and Emerging Treatment Approaches
- The Role of Clinical Trials: How Research Increases Your Treatment Options
- Tips to Manage Symptoms, Treatment Side Effects, Discomfort, Pain & Quality-of-Life Concerns
- Key Questions to Ask Your Health Care Team
- Guidelines to Prepare for Telehealth Appointments including Technology, Prepared List of Questions and Discussion of OpenNotes
- Next Steps After Treatment, Including Follow-up Care in Collaboration with Your Primary Care Doctor and Team
- Questions for Our Panel of Experts
Speakers
Facilitator
Facilitator
Continuing Education Credits
Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Certified Health Education Specialists (CHES®): This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1 total Category I continuing education contact hour. Cancer Care, Inc is a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc.
To request continuing education paperwork, please email your name, profession, and address to [email protected] after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.